Latest filing published 02 Jul 2024 for bioAffinity Technologies, Inc..
Gary D. Rubin is a declared insider of bioAffinity Technologies, Inc., with filings sourced from SEC (Form 4). Between 31 August 2022 and 1 July 2024, the trades on record add up to 15 filings.
On the market, this insider has only ever bought: 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 7 share grants.
The latest filing, published on 2 July 2024, reports a share grant in bioAffinity Technologies, Inc. The most recent open-market purchase was published on 21 October 2022, 1,463 days ago. The median gap between a trade and its publication by SEC (Form 4) is 45 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations